HQL is a mutual fund that focuses on investing in the life sciences industry. It is managed by Tekla Capital Management LLC and offers investors the opportunity to benefit from the growth potential of companies in the healthcare, biotechnology, and pharmaceutical sectors. With a ticker symbol of HQL, this fund provides investors with a diversified portfolio of life sciences companies, allowing them to potentially capitalize on the advancements and innovations in this rapidly evolving industry.